ASCO and Cancer Research
ASCO (the American Society for Clinical Oncology) has just released a report on the progress of cancer research. The short summary is that much as been accomplished, but much more remains to be done. If you want to read a really interesting and informative book about all of this, find a copy of The Emperor of All Maladies. Sadly, I can't copy the book for you, but here is the beginning of the ASCO report and then a link to read more on MedScape:
ASCO Unveils New Vision for Transforming Cancer Research
November 4, 2011 — Although there has been tremendous progress in cancer care during the past 40 years, there is still much to be done to improve patient survival. In a new report, the American Society of Clinical Oncology (ASCO) has issued a detailed "prescription" for transforming clinical research and increasing the pace of drug development.
In the report — entitled Accelerating Progress Against Cancer: ASCO's Blueprint for Transforming Clinical and Translational Cancer Research — the organization puts forward its vision for transforming clinical and translational research, with the goal of delivering more effective and personalized cancer therapies faster.
"ASCO is issuing this report as we approach the 40th anniversary of the signing of the National Cancer Act, in December 1971, by President Richard Nixon," ASCO president Michael Link, MD, said during a media briefing. "That legislation led to an unprecedented investment in cancer research, which has spurred significant increases in survival and revolutionized our biological understanding of cancer."
"While cancer has proven a more far more difficult challenge than anyone could have imagined 40 years ago, we have numerous indications of the progress we have made," he explained.
That said, Dr. Link emphasized that despite the impressive progress, "we still have a long way to go."